A

Ambalal Sarabhai Enterprises Limited

AMBALALSA
Market snapshot · 2026-08-11 03:37 UTC

48.27

+₹1.54 (+3.30%)

MARKET CAP

₹369.91 Cr

STOCK P/E

20.2x

52W HIGH

₹49.98

52W LOW

₹30.15

BOOK VALUE

₹20.66

EPS

₹2.39

ROE

11.94%

SECTOR

Health Care

DEBT/EQUITY

35.70

VOLUME

7.74L

P/B RATIO

2.34x

PEG RATIO

Sector

Health Care

Themes

Pharmaceuticals
₹48.27₹43.93₹39.58₹35.24₹30.89VolumeApr '26May '26May '26Jun '26Jun '26Jul '26Jul '26Aug '26

AI Summary

✦ Clartha

Forecast

Analyst targets, estimate history, and probabilistic forward ranges for AMBALALSA.

Coverage check

Price Forecast

Current
₹48.27
High Target
Median Target
Low Target
Now₹48.27Apr '26Now12M Target
Price history (1Y)
Analyst target range

Probabilistic Range

Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.

Time horizonRange ()Probability
3M₹43.44 - ₹91.0980%
6M₹48.56 - ₹138.3880%
12M₹66.38 - ₹291.9080%
Realized vol: +57.8% · Drift: +122.6%

Revenue Forecast

₹ Cr
Mar '26Current₹2.0
Sep 2026 ETrend estimate range
High₹1.6Base₹1.5Low₹1.4
Mar '25: ₹2.0 · Jun '25: ₹2.0 · Sep '25: ₹1.0 · Mar '26: ₹2.0 · Sep '26: ₹1.5 · Dec '26: ₹3.0
Mar '25Jun '25Sep '25Mar '26Sep '26 EDec '26 E2.02.01.02.01.53.0
PastCurrentTrend estimate: Low / Base / High

EPS Forecast

₹ / share
Mar '26Current₹0.35
Sep 2026 ETrend estimate range
High₹-0.08Base₹-0.08Low₹-0.07
Jun '25: ₹0.90 · Sep '25: ₹-0.05 · Dec '25: ₹0.24 · Mar '26: ₹0.35 · Sep '26: ₹-0.08 · Dec '26: ₹0.36
Jun '25Sep '25Dec '25Mar '26Sep '26 EDec '26 E0.90-0.050.240.35-0.080.36
PastCurrentTrend estimate: Low / Base / High
Analyst price target unavailable from FMP/yfinance. Analyst pillar unavailable from FMP/yfinance.
Market Intelligence

Multi-factor synthesis of 5 key dimensions

Overall Outlook
Cautious
24%
Analyst Consensus
Unavailable

Analyst coverage unavailable

Mean upsideNot available

Fundamentals

Moderate

Fundamentals institutional score is 61 using EVA spread proxy -0.1%; growth durability 77.3.

Valuation

Premium valuation

Valuation institutional score is 2 using relative multiple z-scores where peer dispersion is available.

Analyst Consensus

Unavailable

No usable analyst target or recommendation data was available.

Technical Structure

Weak Structure

Technicals institutional score is 0 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.

Market Sentiment

Unavailable

This data source has not been supplied for the decision payload.

Signal Summary

Market intelligence remains Cautious. Available evidence provides partial support, while valuation and technical structure remain considerations.

Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.

Fundamentals ModerateValuation Premium valuationTechnical Structure Weak Structure

Key Data Points

Mean Target PriceUnavailable
Mean UpsideNot available
Technical Score0%
Fundamental Score61%
Data CoverageMedium

Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.

Valuation Metrics

Trading 47.1% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +2.81). Confidence: 86%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Overvalued

5Y Average

15.81

Current

20.20

Overvalued

14.33

Undervalued

13.36

EV/EBITDA
Strongly Overvalued

5Y Average

14.58

Current

18.63

Overvalued

14.87

Undervalued

13.24

P/S
Strongly Overvalued

5Y Average

1.43

Current

1.83

Overvalued

1.64

Undervalued

1.22

Peers & Comparison

Sector: Healthcare

No peer data available for this company.
WHY THESE PEERS

Peers are filtered to companies with market cap between 0.2x and 5.0x of the primary company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹1.52 CrMar 2026

Latest net profit

₹2.65 CrMar 2026

Latest EPS

₹0.35Mar 2026

Net margin

-89.5%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-210.0%-175.0%-140.0%-105.0%-70.0%-8.00 Cr-4.00 Cr0.00 Cr4.00 Cr8.00 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr0.45 Cr0.90 Cr1.35 Cr1.80 Cr₹-1₹-0₹0₹0₹1
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherOtheradjustmentsNet Profit-2.00 Cr0.00 Cr2.00 Cr4.00 Cr6.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-30 Cr0.00 Cr30 Cr60 Cr90 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +0.371.700.800.330.991.140.001.171.731.640.790.001.52
Expenses +1.664.842.131.961.642.411.803.743.432.832.430.942.88
Operating Profit-1.29-3.14-1.33-1.63-0.65-1.27-1.80-2.57-1.70-1.19-1.64-0.94-1.36
OPM %-348.65%-184.71%-166.25%-493.94%-65.66%-111.40%-219.66%-98.27%-72.56%-207.59%-89.47%
Other Income +2.601.181.961.333.411.886.3710.81-3.218.171.362.893.16
Interest0.050.030.040.060.070.090.090.100.050.070.080.090.17
Depreciation0.030.030.030.030.030.030.030.020.020.020.020.020.02
Profit before tax1.23-2.020.56-0.392.660.494.458.12-4.986.89-0.381.841.61
Tax %8.94%0.00%0.00%69.23%-76.32%6.12%3.15%-3.82%-0.40%0.00%0.00%-0.54%-64.60%
Net Profit +1.12-2.020.56-0.654.700.464.318.43-4.966.88-0.381.842.65
EPS in Rs0.15-0.260.07-0.080.610.060.561.10-0.650.90-0.050.240.35
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +31.35%31.35%31.36%31.36%31.36%
FIIs +0.38%0.34%0.34%
Public +68.26%68.32%68.29%68.64%68.64%
Others0.01%0.01%
Jun 2026
Promoters +
Public +

Events Timeline

Annual Report FY26

FY2026PDFCompany Reports Open

Clarification On Price Movement

Aug 06, 2026PDFCompany Reports Open

Clarification Sought from Ambalal Sarabhai Enterprises Ltd

Aug 05, 2026LinkCompany Reports Open

Plant Visit Updates

Aug 05, 2026PDFCompany Reports Open

Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidate Financial Results Of The Company For Quarter Ended 30.06.2026 Along With Limited Review Report Of Auditors Thereon

Aug 05, 2026PDFCompany Reports Open